2seventy bio Announces Upcoming Investor Events

Rhea-AI Summary

2seventy bio, the upcoming oncology spin-off from bluebird bio (NASDAQ: BLUE), has announced a series of investor events to discuss its research pipeline and strategic direction. The first session, scheduled for September 21, 2021, will focus on AML [DARIC33] and their next-gen multiple myeloma strategy. The second session will take place on September 22, 2021, highlighting bNHL [bbT369] and solid tumor strategies. Investors can access live webcasts and recordings for 90 days post-event via the bluebird bio website.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- 2seventy bio, the planned oncology spin-off of bluebird bio (NASDAQ: BLUE) announced today that it will host a series of investor events to share further detail on its research pipeline and strategy.

• Session One: An Introduction to 2seventy’s Pipeline; focus on AML [DARIC33] and Next-Gen Multiple Myeloma Strategy
  • September 21, 2021, 11:00am-12:00pm ET
• Session Two: Focus on bNHL [bbT369] and Solid Tumor Strategy
  • September 22, 2021, 1:00-2:00pm ET

To access the live webcasts and dial-in information for 2seventy bio’s presentations, please visit the “Events & Presentations” page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005440/en/

Investors & Media

Investors:

Elizabeth Pingpank, 617-914-8736

epingpank@bluebirdbio.com

Media:

Jenn Snyder, 617-448-0281

jsnyder@bluebirdbio.com

Source: bluebird bio

FAQ

What investor events is bluebird bio hosting for 2seventy bio?

bluebird bio is hosting investor events on September 21 and 22, 2021, to discuss 2seventy bio's research pipeline.

When is the session focusing on AML and multiple myeloma scheduled?

The session focused on AML [DARIC33] and next-gen multiple myeloma strategy is scheduled for September 21, 2021, from 11:00 AM to 12:00 PM ET.

What will be discussed in the second investor session?

The second session will focus on bNHL [bbT369] and solid tumor strategies, scheduled for September 22, 2021, from 1:00 PM to 2:00 PM ET.

How can investors access the webcasts for these events?

Investors can access the live webcasts and dial-in information on the 'Events & Presentations' page of the bluebird bio website.

How long will the webcasts be available for replay?

Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.